Stockysis — AI-Powered Stock News & Sentiment Analysis

Back Login to subscribe

15 min delay

Indicators:

Date	Headline	Sentiment
	12 Health Care Stocks Moving In Thursday's Intraday Session	58.36%
	Medicus Pharma shares are trading lower after the company announced topline results from its Phase 2 clinical study evaluating safety and efficacy of Doxorubicin Microneedle Array to non-invasively treat basal cell carcinoma of the skin.	96.15%
	Dow Falls Over 300 Points; Kroger Posts Mixed Results	93.83%
	Medicus Pharma Stock Swings After Skin Cancer Treatment Results	91.99%
	Medicus Pharma Announces Data From Its Phase 2 Clinical Trial Of SKNJCT-003 Shows Clearance Rates Rose Between Day 29 And Day 57; 73% Clinical Clearance Observed	94.35%
	12 Health Care Stocks Moving In Tuesday's Pre-Market Session	49.39%
	12 Health Care Stocks Moving In Monday's After-Market Session	49.39%
	12 Health Care Stocks Moving In Thursday's Pre-Market Session	49.39%
	Medicus Pharma Receives FDA's 'Study May Proceed' Clearance To Start Phase 2B Dose-Optimization Trial Of Teverelix To Treat Advanced Prostate Cancer In Men	22.63%